United States Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests
Description
United States Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests
Summary
GlobalData’s “United States Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests
The United States Reproductive Health Diagnostics Market report provides key information and data on -
United States Reproductive Health Diagnostics is segmented as follows -
The United States Reproductive Health Diagnostics Market report helps you to develop -
Summary
GlobalData’s “United States Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests
The United States Reproductive Health Diagnostics Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Reproductive Health Diagnostics Market.
- Global corporate-level profiles of key companies operating within the United States Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United States Reproductive Health Diagnostics is segmented as follows -
- Prenatal Screening
- Reproductive Hormones and Proteins Tests
The United States Reproductive Health Diagnostics Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Table of Contents
48 Pages
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Reproductive Health Diagnostics Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Reproductive Health Diagnostics Market, United States
- 3.1 Reproductive Health Diagnostics Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Prenatal Screening Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- 3.2.1 Prenatal Screening Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033
- 3.4 Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024
- 4 Overview of Key Companies in United States, Reproductive Health Diagnostics Market
- 4.1 Illumina Inc
- 4.1.1 Company Overview
- 4.2 Quidelortho Corp
- 4.2.1 Company Overview
- 4.3 Danaher Corp
- 4.3.1 Company Overview
- 4.4 F. Hoffmann-La Roche Ltd
- 4.4.1 Company Overview
- 4.5 Siemens AG
- 4.5.1 Company Overview
- 4.6 Abbott Laboratories
- 4.6.1 Company Overview
- 4.7 BGI Genomics Co Ltd
- 4.7.1 Company Overview
- 5 Reproductive Health Diagnostics Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Asset Transactions
- 6.1.1 Astorg Partners Acquires Reproductive Business from Cook Medical for USD282 Million
- 6.2 Venture Financing
- 6.2.1 Novocuff Raises USD26 Million in Series A Funding
- 6.2.2 3Daughters Raises Additional USD4.7 Million in Seed Financing
- 7 Recent Developments
- 7.1 Strategy And Business Planning
- 7.1.1 Apr 22, 2025: Advantia Health Teams Up With Mirvie to Bring Predictive and Preventive Care to Maternal Health
- 7.1.2 Jun 05, 2024: Organabio Expands California CPC Services Hub for Sample Processing and Cryopreservation Capabilities to Support Big Pharma Clinical Trials
- 8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- List of Tables
- Table 1: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- Table 5: Prenatal Screening Market, United States, Volume (Units), 2018-2033
- Table 6: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033
- Table 7: Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033
- Table 8: Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024
- Table 9: Reproductive Health Diagnostics Market Pipeline Products
- Table 10: Astorg Partners Acquires Reproductive Business from Cook Medical for USD282 Million
- Table 11: Novocuff Raises USD26 Million in Series A Funding
- Table 12: 3Daughters Raises Additional USD4.7 Million in Seed Financing
- Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
- List of Figures
- Figure 1: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- Figure 5: Prenatal Screening Market, United States, Volume (Units), 2018-2033
- Figure 6: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033
- Figure 7: Reproductive Health Diagnostics Market, United States, Company Share (%), 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
